With over 20 years of experience at the intersection of scientific research and product development, Dr. Campbell brings a unique blend of expertise in pharmacology, toxicology, and consumer products focused on psychoactive drugs, mood-states, and harm reduction. As the current Managing Partner at Venebio Group/Consilium Sciences, he leads regulatory consulting teams for product development and FDA submissions, having created new verticals in cannabis, psychedelics, and cosmetics.

Dr. Campbell's impressive career spans academia and industry, including roles as Chief Scientific Officer at BREZ, and Systems Biologist at Vanderbilt University. He has published over 20 scientific studies, holds numerous patents, and has led multimillion-dollar research projects. He is also a successful entrepreneur, having founded 3 successful companies in the vapor product, drug development, and cannabis spaces. His expertise in data science, ML/AI applications, and natural product research has driven innovation in drug discovery and consumer product development. With a Ph.D. in Pharmacology from Vanderbilt University and a background that includes founding ENSO Laboratories, Dr. Campbell is well-positioned to share insights on the cutting edge of science and business in today's rapidly evolving marketplace.